Literature DB >> 18282324

Memory impairment, executive dysfunction, and intellectual decline in preclinical Alzheimer's disease.

Ellen Grober1, Charles B Hall, Richard B Lipton, Alan B Zonderman, Susan M Resnick, Claudia Kawas.   

Abstract

In the Baltimore Longitudinal Study of Aging (BLSA), we examined the temporal unfolding of declining performance on tests of episodic memory (Free Recall on the Free and Cued Selective Reminding Test), executive function (Category Fluency, Letter Fluency, and Trails), and Verbal Intelligence (Nelson, 1982; American Version of the Nelson Adult Reading Test [AMNART]) before the diagnosis of dementia in 92 subjects with incident Alzheimer's disease (AD) followed for up to 15 years before diagnosis. To examine the preclinical onset of cognitive decline, we aligned subjects at the time of initial AD diagnosis and examined the cognitive course preceding diagnosis. We found that declines in performance on tests of episodic memory accelerated 7 years before diagnosis. Declining performance on tests of executive function accelerated 2-3 years before diagnosis, and verbal intelligence declined in close proximity to diagnosis. This cognitive profile is compatible with pathologic data suggesting that structures which mediate memory are affected earlier than frontal structures during the preclinical onset of AD. It also supports the view that VIQ as estimated by the AMNART does not decline during the preclinical onset of AD.

Entities:  

Mesh:

Year:  2008        PMID: 18282324      PMCID: PMC2763488          DOI: 10.1017/S1355617708080302

Source DB:  PubMed          Journal:  J Int Neuropsychol Soc        ISSN: 1355-6177            Impact factor:   2.892


  60 in total

1.  Cognitive support at episodic encoding and retrieval: similar patterns of utilization in community-based samples of Alzheimer's disease and vascular dementia patients.

Authors:  O Almkvist; L Fratiglioni; H Agüero-Torres; M Viitanen; L Bäckman
Journal:  J Clin Exp Neuropsychol       Date:  1999-12       Impact factor: 2.475

2.  Mild cognitive impairments predict dementia in nondemented elderly patients with memory loss.

Authors:  A Bozoki; B Giordani; J L Heidebrink; S Berent; N L Foster
Journal:  Arch Neurol       Date:  2001-03

3.  Sensitivity to semantic cuing: an index of episodic memory dysfunction in early Alzheimer disease.

Authors:  H Tounsi; B Deweer; A M Ergis; M Van der Linden; B Pillon; A Michon; B Dubois
Journal:  Alzheimer Dis Assoc Disord       Date:  1999-01       Impact factor: 2.703

4.  Preclinical prediction of AD using neuropsychological tests.

Authors:  M S Albert; M B Moss; R Tanzi; K Jones
Journal:  J Int Neuropsychol Soc       Date:  2001-07       Impact factor: 2.892

5.  Classification criteria for mild cognitive impairment: a population-based validation study.

Authors:  K Ritchie; S Artero; J Touchon
Journal:  Neurology       Date:  2001-01-09       Impact factor: 9.910

6.  Age-specific incidence rates of Alzheimer's disease: the Baltimore Longitudinal Study of Aging.

Authors:  C Kawas; S Gray; R Brookmeyer; J Fozard; A Zonderman
Journal:  Neurology       Date:  2000-06-13       Impact factor: 9.910

7.  A change point model for estimating the onset of cognitive decline in preclinical Alzheimer's disease.

Authors:  C B Hall; R B Lipton; M Sliwinski; W F Stewart
Journal:  Stat Med       Date:  2000 Jun 15-30       Impact factor: 2.373

Review 8.  Differentiation of vascular dementia from AD on neuropsychological tests.

Authors:  J C Looi; P S Sachdev
Journal:  Neurology       Date:  1999-09-11       Impact factor: 9.910

9.  Memory impairment on free and cued selective reminding predicts dementia.

Authors:  E Grober; R B Lipton; C Hall; H Crystal
Journal:  Neurology       Date:  2000-02-22       Impact factor: 9.910

10.  The preclinical phase of alzheimer disease: A 22-year prospective study of the Framingham Cohort.

Authors:  M F Elias; A Beiser; P A Wolf; R Au; R F White; R B D'Agostino
Journal:  Arch Neurol       Date:  2000-06
View more
  172 in total

Review 1.  Changes in cognition.

Authors:  Marilyn S Albert
Journal:  Neurobiol Aging       Date:  2011-12       Impact factor: 4.673

2.  Neurodegenerative basis of age-related cognitive decline.

Authors:  R S Wilson; S E Leurgans; P A Boyle; J A Schneider; D A Bennett
Journal:  Neurology       Date:  2010-09-15       Impact factor: 9.910

3.  Neuropsychological Markers of Cognitive Decline in Persons With Alzheimer Disease Neuropathology.

Authors:  Jason Hassenstab; Sarah E Monsell; Charles Mock; Catherine M Roe; Nigel J Cairns; John C Morris; Walter Kukull
Journal:  J Neuropathol Exp Neurol       Date:  2015-11       Impact factor: 3.685

Review 4.  Amyloid positron emission tomography and cognitive reserve.

Authors:  Matteo Bauckneht; Agnese Picco; Flavio Nobili; Silvia Morbelli
Journal:  World J Radiol       Date:  2015-12-28

Review 5.  Perturbations of neural circuitry in aging, mild cognitive impairment, and Alzheimer's disease.

Authors:  Stephanie L Leal; Michael A Yassa
Journal:  Ageing Res Rev       Date:  2013-02-04       Impact factor: 10.895

6.  Hippocampal proNGF signaling pathways and β-amyloid levels in mild cognitive impairment and Alzheimer disease.

Authors:  Elliott J Mufson; Bin He; Muhammad Nadeem; Sylvia E Perez; Scott E Counts; Sue Leurgans; Jason Fritz; James Lah; Stephen D Ginsberg; Joanne Wuu; Stephen W Scheff
Journal:  J Neuropathol Exp Neurol       Date:  2012-11       Impact factor: 3.685

Review 7.  The Alzheimer's prevention initiative composite cognitive test score: sample size estimates for the evaluation of preclinical Alzheimer's disease treatments in presenilin 1 E280A mutation carriers.

Authors:  Napatkamon Ayutyanont; Jessica B S Langbaum; Suzanne B Hendrix; Kewei Chen; Adam S Fleisher; Michel Friesenhahn; Michael Ward; Camilo Aguirre; Natalia Acosta-Baena; Lucìa Madrigal; Claudia Muñoz; Victoria Tirado; Sonia Moreno; Pierre N Tariot; Francisco Lopera; Eric M Reiman
Journal:  J Clin Psychiatry       Date:  2014-06       Impact factor: 4.384

8.  Development of a psychometrically equivalent short form of the Face-Name Associative Memory Exam for use along the early Alzheimer's disease trajectory.

Authors:  Kathryn V Papp; Rebecca E Amariglio; Maria Dekhtyar; Kamolika Roy; Sarah Wigman; Rose Bamfo; Julia Sherman; Reisa A Sperling; Dorene M Rentz
Journal:  Clin Neuropsychol       Date:  2014-05-12       Impact factor: 3.535

9.  Practice effects and longitudinal cognitive change in normal aging vs. incident mild cognitive impairment and dementia in the Mayo Clinic Study of Aging.

Authors:  Mary M Machulda; V Shane Pankratz; Teresa J Christianson; Robert J Ivnik; Michelle M Mielke; Rosebud O Roberts; David S Knopman; Bradley F Boeve; Ronald C Petersen
Journal:  Clin Neuropsychol       Date:  2013-09-17       Impact factor: 3.535

10.  Linear Combinations of Multiple Outcome Measures to Improve the Power of Efficacy Analysis ---Application to Clinical Trials on Early Stage Alzheimer Disease.

Authors:  Chengjie Xiong; Jingqin Luo; John C Morris; Randall Bateman
Journal:  Biostat Epidemiol       Date:  2017-06-02
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.